METiS Therapeutics
PrivateLast Round
IPO
May 13, 2026
Est. Valuation
$1.55B
Total Funding Raised
$305M
Company Overview
METiS Therapeutics is a biotechnology company that leverages artificial intelligence, machine learning, and quantum simulation to drive drug discovery and optimize pharmaceutical formulation processes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
METiS Therapeutics Comparables
Compare METiS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XtalPi | 85% | |
| Insilico Medicine | 80% | |
| Valo Health | 76% | |
METiS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | May 13, 2026 | ||||
| Series D | Aug 4, 2025 | ||||
| Series C | Jun 24, 2024 | ||||
| Series B | Apr 6, 2022 | ||||
| Series A | Dec 7, 2021 | ||||
Angel | Dec 3, 2020 |
METiS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | IPO |
| IDG Capital | IPO |
| Lake Bleu Capital | IPO |
| CCIC Capital | Series D |
| Mirae Asset | IPO |
| Hillhouse Investment | IPO |
| 招银国际金融有限公司 | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 7, 2021
Raised $86M led by PICC Capital Insurance Asset Management.
- Mar 23, 2020
Led by Frees Fund with participation from Source Code Capital.
METiS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about METiS Therapeutics's valuation, stock price, and market status.